Alliqua’s CEO Issues Letter to Shareholders
Alliqua to List on the NASDAQ Capital Market on January 28, 2014
Alliqua Appoints Perry A. Karsen to Board of Directors
Alliqua Announces Transaction with Celgene
Alliqua Announces Reverse Split of Common Stock
Alliqua Receives $1M from Crossover Healthcare Fund, LLC to Pursue Key Wound Care Initiatives
Alliqua Signs Distribution Agreement for SilverSeal® and Hydress® Wound Dressings
Preclinical Results Show Alliqua's Investigational Lidocaine Transdermal Patch Compares Favorably to Lidoderm Patch
Alliqua Provides Update on Media Coverage of its Advanced Wound Care Portfolio and Corporate Developments
